since the goal of factor viii potency measurement is to predict therapeutic effect , the use of factor viii deficient plasma is the more satisfactory alternative where a difference exists , since this diluent approximates best the conditions which occur when a factor viii concentrate is injected into the bloodstream of a patient with hemophilia a .
C0015506
factor viii
C0019069
hemophilia a